Lunit Partnering with Daiichi Sankyo to Bring AI-Powered Pathology Analysis into Two of Daiichi Sankyo’s Oncology Research and Development Programs to Facilitate Faster Biomarker...
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing & enhance precision medicine capabilities
Lunit, a leading provider of artificial intelligence...
Lunit, a leading provider of AI for cancer diagnostics and therapeutics, announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions....
Lunit, a leading innovator in AI for cancer diagnostics and therapeutics, announced a strategic partnership with Starvision Service GmbH, Germany's largest private radiology network....
SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce their partnership with Lunit,...
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
Lunit, a leading...
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the publication of a new study featuring Lunit SCOPE IO, Lunit's...